Stock Taper 
DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Cytokinetics, Incorporated | CYTK | 172K | $14.65M |
 MapLight Therapeutics, Inc. | MPLT | 171.01K | $6.13M |
 Editas Medicine, Inc. | EDIT | 170.47K | $552.32K |
 ARS Pharmaceuticals, Inc. | SPRY | 164.28K | $1.32M |
 Immunovant, Inc. | IMVT | 149.52K | $5.76M |
 Biohaven Ltd. | BHVN | 137.59K | $2.05M |
 SCYNEXIS, Inc. | SCYX | 135.87K | $552.98K |
 Stoke Therapeutics, Inc. | STOK | 130.88K | $4.28M |
 Atrium Therapeutics, Inc. | RNA | 128K | $1.72M |
 Kura Oncology, Inc. | KURA | 120.57K | $1.32M |
 PROCEPT BioRobotics Corporation | PRCT | 120K | $2.71M |
 Design Therapeutics, Inc. | DSGN | 102.6K | $1.48M |
 Alkermes plc | ALKS | 101.27K | $5.31M |
 MediWound Ltd. | MDWD | 94.41K | $1.39M |
 DexCom, Inc. | DXCM | 86.28K | $5.81M |
 Rapport Therapeutics, Inc. Common Stock | RAPP | 75K | $3.13M |
 Celldex Therapeutics, Inc. | CLDX | 68.52K | $2.55M |
 Insulet Corp. | PODD | 61.87K | $9.42M |
 Viking Therapeutics, Inc. | VKTX | 59.52K | $2.32M |
 Neurocrine Biosciences, Inc. | NBIX | 57.77K | $9.74M |